Industry Briefs: Feb. 27, 2012
A roundup of additional company and people news from pharmaceutical and biopharmaceutical companies, their suppliers, and contract-service providers.
Company News
Almac has acquired two pieces of encapsulation equipment for its North American headquarters in Souderton, Pennsylvania.
Angiochem and GlaxoSmithKline have formed a collaboration to discover, develop, and commercialize treatments for lysosomal storage diseases.
Auxilium Pharmaceuticals and Actelion Pharmaceuticals have formed a collaboration agreement for Xiaflex (collagenase clostridium histolyticum).
BASF has launched a white biotechnology and microbiology research laboratory at its Tarrytown, New York, facility.
Boehringer Ingelheim and Xencor have formed a collaboration agreement for the development, manufacture, and supply of biosuperior monoclonal antibodies.
EMD Millipore has partnered with Charles River Laboratories for viral-clearance studies.
In other news, EMD Millipore has opened its first laboratory water-production site in China.
Haupt Pharma and the Fraunhofer Institute optimize Haupt’s supply-chain capabilities.
Hospira has joined the Generic Pharmaceutical Association (GPhA).
Penn Pharma plans a £14-million ($22.2 million) investment in its South Wales, United Kingdom, facility to increase its global supply and its high-containment manufacturing capabilities.
Pfizer has acquired Alacer, a vitamin supplements company.
Roche has extended its tender offer for Illumina.
Sol-Gel has signed a $24.7-million agreement with an undisclosed pharmaceutical company for the development and commercialization in the United States and Canada of a dermatologic drug.
People News
Amarillo Biosciences has appointed Stephen Chen as chairman and CEO. Joseph Cummins will remain as president and chief operating officer.
DPT Laboratories has named Kuljit Bhatia as vice-president of R&D.
Johnson & Johnson’s (J&J) board of directors has named Alex Gorsky to succeed Bill Weldon as CEO, effective Apr. 26, 2012. Gorsky was also nominated for election to the board of directors at J&J’s annual meeting of shareholders.
Mylan North America President Tony Mauro has been elected chairman of GPhA.
OSO BioPharmaceuticals has appointed Marian Meyer as director of laboratories.
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
